Robinson Pharma IncAugust 30, 2017

FDA 483 - Robinson Pharma Inc - August 30, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Robinson Pharma Inc

Record Details

Robinson Pharma Inc, a dietary supplement manufacturer in Santa Ana, CA, was inspected by the FDA from August 24-30, 2017. The inspection revealed that the firm's quality control operations failed to review and approve all batch production-related records. Specifically, products were shipped to customers before final Certificates of Analysis were generated and before all batch records were reviewed and signed for release.

Company: Robinson Pharma Inc
Inspection Date: August 30, 2017
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations IV
Person: Tawny L. Colling (investigator)

Open in Dashboard

ID · 520055a7-d707-43e2-aa24-11ee64f8a2d8